<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03044808</url>
  </required_header>
  <id_info>
    <org_study_id>13.024</org_study_id>
    <secondary_id>2014-003466-25</secondary_id>
    <nct_id>NCT03044808</nct_id>
  </id_info>
  <brief_title>Investigation of the Effect of Intravenous Lidocaine Infusion on Postoperative Pain Treatment and Bowel Function in Robotic Bowel Surgery</brief_title>
  <official_title>Randomized Double Blind Prospective Investigation of the Effect of Intravenous Lidocaine Infusion on Postoperative Pain Treatment and Bowel Function in Robotic Bowel Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single center double blind randomised controlled trial. 60 subjects. Giving lidocaine IV or
      saline to patients due to robot assisted colorectal surgery. Primary outcome is cumulative
      morphine consumption at 24 hours.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective double blind randomised controlled trial. The investigators are giving lidocaine
      IV or saline to 60 patients undergoing robot assisted colorectal surgery. Blinding and
      randomization is done by the hospital pharmacy. Both groups get otherwise the same treatment
      and a IV PCA (patient controlled administration) morphine pump for objectivisation of opioid
      consumption. Other outcome measures are NRS (numerical rating score) pain score, PONV
      (postoperative nausea and vomiting), use of antiemetics and opioid consumption up to 72
      hours.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2, 2016</start_date>
  <completion_date type="Actual">April 19, 2017</completion_date>
  <primary_completion_date type="Actual">April 19, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2 randomized groups, one getting lidocaine and the other getting saline</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Pharmacy provides the research medicine, it is not possible to see a difference. The envelopes are &quot;encrypted&quot;. The randomization will only be broken in the end.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in morphine consumption</measure>
    <time_frame>over the first 24 hours</time_frame>
    <description>PCA morphine added to PN (per necessitae) morphine, cumulated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PONV</measure>
    <time_frame>up to 72 hours</time_frame>
    <description>Postoperative nausea and vomiting - patient is asked</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in morphine consumption</measure>
    <time_frame>over the first 72hours</time_frame>
    <description>PCA morphine added to PN morphine, cumulated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of antiemetics postoperative</measure>
    <time_frame>first 72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to bowel function</measure>
    <time_frame>first 72 hours</time_frame>
    <description>time to flatus or defecation or function of bowel stoma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to discharge</measure>
    <time_frame>up to 72 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Opioid Use</condition>
  <arm_group>
    <arm_group_label>Lidocain</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient gets the experimental treatment with IV lidocain 0,5mg/ml, 1,5mg/kg bolus before induction of anesthesia, after that infusion of 1,5mg/kg/h is started and continued until 2 hours after end of surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients get the same amount in ml and duration as if it was the experimental arm. Only in this arm it is isotonic saline instead.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <arm_group_label>Lidocain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients due to robotic laparoscopic colorectal surgery, &gt; 18years of age, danish
             speaking

        Exclusion Criteria:

          -  allergy to lidocain or amid local analgetics, atrioventricular blok, liver- and/or
             kidney failure, chronic use of opioids or NSAIDS, pregnancy, breastfeeding women,
             treatment with betablockers, porphyria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Odense Universitetshospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2017</study_first_submitted>
  <study_first_submitted_qc>February 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2017</study_first_posted>
  <last_update_submitted>September 18, 2017</last_update_submitted>
  <last_update_submitted_qc>September 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Jan Herzog</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

